OM Pharma

OM Pharma is a globally recognized Swiss biopharmaceutical company headquartered in Geneva, specializing in the development and commercialization of innovative therapies that strengthen the immune system. With a strong scientific heritage and decades of expertise, the company focuses on addressing some of the world’s most pressing healthcare challenges, including infectious diseases and antimicrobial resistance.

Founded in 1937, OM Pharma has built a solid reputation for its pioneering work with bacterial lysates—unique biologically derived compounds designed to train and enhance the body’s natural immune defenses. These therapies are widely used for the prevention of recurrent respiratory and urinary tract infections, helping to reduce disease burden and improve patients’ quality of life.

Driven by a commitment to innovation and patient-centered care, OM Pharma continuously invests in research and development to expand its therapeutic portfolio and explore new medical applications. The company combines advanced scientific knowledge with cutting-edge manufacturing capabilities, ensuring high-quality pharmaceutical solutions that meet international standards.

With operations in more than 100 countries and a strong network of global partners, OM Pharma plays a vital role in improving public health worldwide. Its mission is to transform immune health through preventive medicine, empowering individuals and healthcare systems to better manage and reduce the impact of infectious diseases.

Guided by core values such as trust, innovation, and excellence, OM Pharma remains dedicated to advancing modern medicine and delivering reliable, effective treatments that support long-term health and well-being.